{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T15:44:34Z","timestamp":1762098274959},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2006,10,1]],"date-time":"2006-10-01T00:00:00Z","timestamp":1159660800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[2006,10]]},"DOI":"10.1007\/s11239-006-8952-4","type":"journal-article","created":{"date-parts":[[2006,9,28]],"date-time":"2006-09-28T14:27:38Z","timestamp":1159453658000},"page":"103-110","source":"Crossref","is-referenced-by-count":53,"title":["The role of aspirin resistance on outcome in patients with acute coronary syndrome and the effect of clopidogrel therapy in the prevention of major cardiovascular events"],"prefix":"10.1007","volume":"22","author":[{"given":"Burak","family":"Pamukcu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huseyin","family":"Oflaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aytac","family":"Oncul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Berrin","family":"Umman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fehmi","family":"Mercanoglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa","family":"Ozcan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet","family":"Meric","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yilmaz","family":"Nisanci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"8952_CR1","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1016\/0002-8703(91)90275-M","volume":"122","author":"PM Ridker","year":"1991","unstructured":"Ridker PM, Manson JE, Buring JE et al. (1991) The effect of chronic platelet inhibition with low dose aspirin on atherosclerotic progression and acute thrombosis: Clinical evidence from Physicians Health Study. Am Heart J 122:1588\u20131592","journal-title":"Am Heart J"},{"key":"8952_CR2","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/bmj.308.6921.81","volume":"308","author":"Antiplatelet Trialists\u2019 Collaboration","year":"1994","unstructured":"Antiplatelet Trialists\u2019 Collaboration (1994) Collaborative overview of randomized trials of antiplatelet therapy I. Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 308:81\u2013106","journal-title":"BMJ"},{"issue":"3","key":"8952_CR3","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0002-9149(01)01631-9","volume":"88","author":"PA Gum","year":"2001","unstructured":"Gum PA, Kottke-Marchant K, Poggio ED et al. (2001) Profile and prevalence of aspirin resistance in patients with cardiovascular disease. Am J Cardiol 88(3):230\u2013235","journal-title":"Am J Cardiol"},{"key":"8952_CR4","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1161\/01.CIR.96.4.1109","volume":"96","author":"F Cipollone","year":"1997","unstructured":"Cipollone F, Patrignani P, Greco A et al. (1997) Differential suppression of thromboxane biosynthesis by indobufen and aspirin in patients with unstable angina pectoris. Circulation 96:1109\u20131116","journal-title":"Circulation"},{"key":"8952_CR5","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1161\/hc3401.093152","volume":"104","author":"F Cipollone","year":"2001","unstructured":"Cipollone F, Prontera C, Pini B et al. (2001) Overexpression of functionally coupled cyclooxygenase-2 and prostaglandin E synthase in symptomatic atherosclerotic plaques as a basis of prostaglandin E(2)-dependent plaque instability. Circulation 104:921\u2013927","journal-title":"Circulation"},{"key":"8952_CR6","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1161\/01.CIR.102.8.840","volume":"102","author":"O Belton","year":"2000","unstructured":"Belton O, Byrne D, Kearney D et al. (2000) Cyclooxygenase-1 and -2-dependent prostacyclin formation in patients with atherosclerosis. Circulation 102:840\u2013845","journal-title":"Circulation"},{"key":"8952_CR7","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1161\/01.CIR.89.5.1951","volume":"89","author":"PT Larsson","year":"1994","unstructured":"Larsson PT, Wallen NH, Hjemdahl P (1994) Norepinephrine-induced human platelet activation in vivo is only partly counteracted by aspirin. Circulation 89:1951\u20131957","journal-title":"Circulation"},{"key":"8952_CR8","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11239-005-2318-1","volume":"20","author":"B Pamukcu","year":"2005","unstructured":"Pamukcu B, Oflaz H, Acar RD, Umman S, Koylan N, Umman B, Nisanci Y (2005) The role of exercise on platelet aggregation in patients with stable coronary artery disease: exercise induces aspirin resistant platelet activation. J Thromb Thrombolysis 20:17\u201322","journal-title":"J Thromb Thrombolysis"},{"key":"8952_CR9","first-page":"479","volume":"105","author":"JW Davis","year":"1985","unstructured":"Davis JW, Hartman CR, Lewis HD et al. (1985) Cigarette smoking-induced enhancement of platelet function: lack of prevention by aspirin in men with coronary artery disease. J Lab Clin Med 105:479\u2013483","journal-title":"J Lab Clin Med"},{"key":"8952_CR10","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1172\/JCI115032","volume":"87","author":"MT Santos","year":"1991","unstructured":"Santos MT, Valles J, Marcus AJ et al. (1991) Enhancement of platelet reactivity and modulation of eicosanoid production by intact erythrocytes. J Clin Invest 87:572\u2013580","journal-title":"J Clin Invest"},{"key":"8952_CR11","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1161\/01.STR.31.3.591","volume":"31","author":"T Kawasaki","year":"2000","unstructured":"Kawasaki T, Ozeki Y, Igawa T et al. (2000) Increased platelet sensitivity to collagen in individuals resistant to low-dose aspirin. Stroke 31:591\u2013595","journal-title":"Stroke"},{"key":"8952_CR12","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1161\/01.CIR.93.6.1201","volume":"93","author":"N Maalej","year":"1996","unstructured":"Maalej N, Folts JD (1996) Increased shear stress overcomes the anti-thrombotic platelet inhibitory effect of aspirin in stenosed dog coronary arteries. Circulation 93:1201\u20131205","journal-title":"Circulation"},{"key":"8952_CR13","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1161\/01.ATV.17.11.2309","volume":"17","author":"C Patrono","year":"1997","unstructured":"Patrono C, FitzGerald GA (1997) Isoprostanes: potential markers of oxidant stress in atherothrombotic disease. Arterioscler Thromb Vasc Biol 17:2309\u20132315","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"8952_CR14","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1055\/s-0037-1613290","volume":"88","author":"SA McKee","year":"2002","unstructured":"McKee SA, Sane DC, Deliargyris EN (2002) Aspirin resistance in cardiovascular disease: A review of prevalence, mechanisms, and clinical significance. Thromb Haemost 88:711\u2013715","journal-title":"Thromb Haemost"},{"key":"8952_CR15","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0735-1097(03)00921-5","volume":"42","author":"L Macchi","year":"2003","unstructured":"Macchi L, Christiaens L, Brabant S et al. (2003) Resistance in vitro to low-dose aspirin is associated with platelet Pl A1 (GP IIIa) polymorphism but not with C807T (GP Ia\/I\u0131 a) and C-5T Kozak (GP Ib\u03b1) polymorphisms. J Am Coll Cardiol 42:1115\u20131119","journal-title":"J Am Coll Cardiol"},{"key":"8952_CR16","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.ahj.2004.10.007","volume":"149","author":"B Pamukcu","year":"2005","unstructured":"Pamukcu B, Oflaz H, Nisanci Y (2005) The role of platelet glycoprotein IIIa polymorphism in the high prevalence of in vitro aspirin resistance in patients with intracoronary stent restenosis. Am Heart J 149:675\u2013680","journal-title":"Am Heart J"},{"key":"8952_CR17","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S0735-1097(02)03014-0","volume":"41","author":"PA Gum","year":"2003","unstructured":"Gum PA, Kottke-Marchant K, Welsh PA et al. (2003) A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease. J Am Coll Cardiol 41:961\u2013965","journal-title":"J Am Coll Cardiol"},{"key":"8952_CR18","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/00062752-200209000-00004","volume":"9","author":"EJ Favaloro","year":"2002","unstructured":"Favaloro EJ (2002) Clinical application of the PFA-100. Curr Opin Hematol 9:407\u2013415","journal-title":"Curr Opin Hematol"},{"key":"8952_CR19","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1055\/s-0032-1313613","volume":"21","author":"EF Mammen","year":"1995","unstructured":"Mammen EF, Alsbameeri RS, Comp PC (1995) Preliminary data from a field trial of the PFA-100\u00ae system. Semin Thromb Hemost 21:113\u2013121","journal-title":"Semin Thromb Hemost"},{"key":"8952_CR20","doi-asserted-by":"crossref","unstructured":"Mueller MR, Salat A, Stangl P et al. (1997) Variable platelet response to low-dose ASA and the risk of limb deterioration in patients submitted to peripheral arterial angioplasty. Thromb Haemost 78:1003\u20131007","DOI":"10.1055\/s-0038-1657677"},{"key":"8952_CR21","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0049-3848(93)90164-J","volume":"71","author":"KH Grotemeyer","year":"1993","unstructured":"Grotemeyer KH, Scharafinski HW, Husstedt IW et al. (1993) Two-Year follow-up of aspirin responder and aspirin non responder a pilot-study including 180 post-stroke patients. Thromb Research 71:397\u2013403","journal-title":"Thromb Research"},{"key":"8952_CR22","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00415-003-0954-y","volume":"250","author":"K Grundmann","year":"2003","unstructured":"Grundmann K, Jaschonek K, Kleine B et al. (2003) Aspirin non-responder status in patients with recurrent cerebral ischemic attacks. J Neurol 250:63\u201366","journal-title":"J Neurol"},{"key":"8952_CR23","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","volume":"348","author":"CAPRIE Steering committee","year":"1996","unstructured":"CAPRIE Steering committee (1996) A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 348:1329\u20131339","journal-title":"Lancet"},{"key":"8952_CR24","doi-asserted-by":"crossref","unstructured":"Mehta SR, Yusuf S, Peters RJ et al. (2001) Effects of pretreatment with clopidogrel and aspirin followed bu long-term therapy in patients undergoing percutaneous coronary intervention: The PCI-CURE study. Lancet 358:527\u2013533.","DOI":"10.1016\/S0140-6736(01)05701-4"},{"key":"8952_CR25","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1001\/jama.288.19.2411","volume":"288","author":"The CREDO Investigators","year":"2002","unstructured":"The CREDO Investigators (2002) Clopidogrel for reduction of events during observation. JAMA 288:2411\u20132420","journal-title":"JAMA"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-006-8952-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11239-006-8952-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-006-8952-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T11:01:32Z","timestamp":1559386892000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11239-006-8952-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,10]]}},"alternative-id":["8952"],"URL":"https:\/\/doi.org\/10.1007\/s11239-006-8952-4","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"value":"0929-5305","type":"print"},{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,10]]}}}